Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of trivalent rotavirus P2-VP8 subunit vaccine in infants in Africa and India
PACTR201907491834482Phase 3Recruiting
- Sponsor
- PATH
- Start
- Jul 2019
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
Phase 3, randomised trial in rotaviral diarrhea comparing Trivalent rotavirus P2-VP8 subunit vaccine with Rotarix comparator (2 arms). Started Jul 2019; status: recruiting.
02
Drugs
trivalent P2-VP8 subunit rotavirus vaccinehuman rotavirus RIX4414 strain vaccine
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on PACTR201907491834482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201907491834482.